FIELD: medicine.
SUBSTANCE: method involves a drug-induced correction of the gastric secretion, a bile-expelling and antihelicobacter therapy. An epigastric region, and then a projection of a gall bladder are exposed to a red narrow-band optical emission generated by a light-emitting diode. The exposure is continuous, and lasts for 4-5 min per each region. A wave length is 650 nm at an emissive power of 100% generated by Spectrum LC apparatus. The technique is stable. The therapeutic course is 8-10 procedures conducted daily or every second day.
EFFECT: relieving clinical manifestations of the disease, normalising the gastric or duodenal mucosa ensured by the anti-inflammatory effect of the red emission generated by the light-emitting diode.
1 tbl, 1 ex
